Cell and Gene Therapy Chain of Identity Needs a Verifiable Handoff
Cell and gene therapy programmes need a chain of identity that stays visible from collection through release, treatment, and follow-up.
By Arman K
Read brief
Global signal desk
Healthcare intelligence for the people reading the market.
Global Healthcare News tracks the business signals behind care delivery, policy, life sciences, health technology, devices, diagnostics, and market movement.
Policy shifts
Care delivery
Health tech
Life sciences
581published stories
24reference pages
19coverage signals
Lead briefing
Intelligence map
Track the archive by operating signal
Healthcare Services Research
Provider operations, staffing, and delivery models across hospitals and care networks.
Healthcare IT Research
Digital infrastructure, workflow software, analytics, and security.
Medical Device Research
Devices, diagnostics, and the systems that support clinical workflows.
Biotechnology Research
Biotech platforms, pipelines, and commercialization signals.
Pharmaceutical Research
Drug development, manufacturing, approval cycles, and market movement.
Testing & Services Research
Testing, certification, and quality systems across healthcare and adjacent markets.
Life Sciences Research
Laboratory science, commercialization, and industry structure.
Machinery & Equipment Research
Equipment, machinery, and infrastructure supporting healthcare operations.
Briefings
Recent market notes and reports
Biomanufacturing Single-Use Systems Need a Change-Control Map
Biomanufacturing single-use systems are useful only when material choice, process fit, supplier change, and quality review remain connected.
By Arman K
Read brief
Clinical Biomarker Validation Needs a Decision Boundary
Clinical biomarker validation becomes decision-ready when the intended use, specimen, threshold, population, and action are defined together.
By Arman K
Read brief
Biosimilar Interchangeability Needs a Prescribing Workflow
Biosimilar interchangeability is not only a product question. It also depends on prescribing, dispensing, records, communication, and follow-up.
By Arman K
Read brief
Latest briefings
Fresh stories from the live archive
Biorepository Sample Governance Needs a Traceable Record
Biorepository sample governance works when consent, identity, storage, access, use, and disposition can be traced without ambiguity.
By Arman K
Read brief
Synthetic Biology Containment Needs an Operating Boundary
Synthetic biology containment needs a practical operating boundary that connects design, facility controls, training, incident response, and review.
By Arman K
Read brief
Companion Diagnostics Evidence Needs a Treatment Link
Companion diagnostics evidence matters when the test result changes a defined treatment decision for the population being served.
By Arman K
Read brief
Genomic Data Consent Needs a Reuse Boundary
Genomic data consent needs a clear reuse boundary so participants, researchers, custodians, and downstream users understand what may happen next.
By Arman K
Read brief
Therapeutic Protein Immunogenicity Needs a Follow-Up Plan
Therapeutic protein immunogenicity assessment is strongest when sampling, interpretation, clinical context, and follow-up are designed as one pathway.
By Arman K
Read brief
Cell Processing Facilities Need a Release-Readiness Record
Cell processing facilities need a release-readiness record that joins identity, quality, environmental control, deviations, and the treatment decision.
By Arman K
Read brief
Global Health Security Needs a Supply Chain Evidence Trail
Global health security is not only a preparedness policy. It is an operating chain that must connect risk signals, supplies, laboratories, workforce, decisions, and public trust.
By Arman K
Read brief